Full text
36,271 characters
· extracted from
preprint-html
· click to expand
Expression of the naked mole-rat transgene for Has2 improved health span in C57Bl/6 mice, but it did not attenuate age-related hearing loss | bioRxiv /* */ /* */ <!-- <!-- /*! * yepnope1.5.4 * (c) WTFPL, GPLv2 */ (function(a,b,c){function d(a){return"[object Function]"==o.call(a)}function e(a){return"string"==typeof a}function f(){}function g(a){return!a||"loaded"==a||"complete"==a||"uninitialized"==a}function h(){var a=p.shift();q=1,a?a.t?m(function(){("c"==a.t?B.injectCss:B.injectJs)(a.s,0,a.a,a.x,a.e,1)},0):(a(),h()):q=0}function i(a,c,d,e,f,i,j){function k(b){if(!o&&g(l.readyState)&&(u.r=o=1,!q&&h(),l.onload=l.onreadystatechange=null,b)){"img"!=a&&m(function(){t.removeChild(l)},50);for(var d in y[c])y[c].hasOwnProperty(d)&&y[c][d].onload()}}var j=j||B.errorTimeout,l=b.createElement(a),o=0,r=0,u={t:d,s:c,e:f,a:i,x:j};1===y[c]&&(r=1,y[c]=[]),"object"==a?l.data=c:(l.src=c,l.type=a),l.width=l.height="0",l.onerror=l.onload=l.onreadystatechange=function(){k.call(this,r)},p.splice(e,0,u),"img"!=a&&(r||2===y[c]?(t.insertBefore(l,s?null:n),m(k,j)):y[c].push(l))}function j(a,b,c,d,f){return q=0,b=b||"j",e(a)?i("c"==b?v:u,a,b,this.i++,c,d,f):(p.splice(this.i++,0,a),1==p.length&&h()),this}function k(){var a=B;return a.loader={load:j,i:0},a}var l=b.documentElement,m=a.setTimeout,n=b.getElementsByTagName("script")[0],o={}.toString,p=[],q=0,r="MozAppearance"in l.style,s=r&&!!b.createRange().compareNode,t=s?l:n.parentNode,l=a.opera&&"[object Opera]"==o.call(a.opera),l=!!b.attachEvent&&!l,u=r?"object":l?"script":"img",v=l?"script":u,w=Array.isArray||function(a){return"[object Array]"==o.call(a)},x=[],y={},z={timeout:function(a,b){return b.length&&(a.timeout=b[0]),a}},A,B;B=function(a){function b(a){var a=a.split("!"),b=x.length,c=a.pop(),d=a.length,c={url:c,origUrl:c,prefixes:a},e,f,g;for(f=0;f<d;f++)g=a[f].split("="),(e=z[g.shift()])&&(c=e(c,g));for(f=0;f<b;f++)c=x[f](c);return c}function g(a,e,f,g,h){var i=b(a),j=i.autoCallback;i.url.split(".").pop().split("?").shift(),i.bypass||(e&&(e=d(e)?e:e[a]||e[g]||e[a.split("/").pop().split("?")[0]]),i.instead?i.instead(a,e,f,g,h):(y[i.url]?i.noexec=!0:y[i.url]=1,f.load(i.url,i.forceCSS||!i.forceJS&&"css"==i.url.split(".").pop().split("?").shift()?"c":c,i.noexec,i.attrs,i.timeout),(d(e)||d(j))&&f.load(function(){k(),e&&e(i.origUrl,h,g),j&&j(i.origUrl,h,g),y[i.url]=2})))}function h(a,b){function c(a,c){if(a){if(e(a))c||(j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}),g(a,j,b,0,h);else if(Object(a)===a)for(n in m=function(){var b=0,c;for(c in a)a.hasOwnProperty(c)&&b++;return b}(),a)a.hasOwnProperty(n)&&(!c&&!--m&&(d(j)?j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}:j[n]=function(a){return function(){var b=[].slice.call(arguments);a&&a.apply(this,b),l()}}(k[n])),g(a[n],j,b,n,h))}else!c&&l()}var h=!!a.test,i=a.load||a.both,j=a.callback||f,k=j,l=a.complete||f,m,n;c(h?a.yep:a.nope,!!i),i&&c(i)}var i,j,l=this.yepnope.loader;if(e(a))g(a,0,l,0);else if(w(a))for(i=0;i (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0];var j=d.createElement(s);var dl=l!='dataLayer'?'&l='+l:'';j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;j.type='text/javascript';j.async=true;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-M677548'); Skip to main content Home About Submit ALERTS / RSS Search for this keyword Advanced Search New Results Expression of the naked mole-rat transgene for Has2 improved health span in C57Bl/6 mice, but it did not attenuate age-related hearing loss View ORCID Profile Connor E. Owens , Aiden J. Borruso , Kevin A. Place , Andrei Seluanov , Vera Gorbunova , View ORCID Profile Patricia M. White , Ned J. Place doi: https://doi.org/10.1101/2025.07.27.667071 Connor E. Owens 1 Department of Population Medicine and Diagnostic Sciences, Cornell University College of Veterinary Medicine , Ithaca, NY, USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Connor E. Owens Aiden J. Borruso 1 Department of Population Medicine and Diagnostic Sciences, Cornell University College of Veterinary Medicine , Ithaca, NY, USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Kevin A. Place 1 Department of Population Medicine and Diagnostic Sciences, Cornell University College of Veterinary Medicine , Ithaca, NY, USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Andrei Seluanov 2 Department of Biology, University of Rochester , Rochester, NY, USA 3 Department of Medicine, University of Rochester Medical Center , NY, USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Vera Gorbunova 2 Department of Biology, University of Rochester , Rochester, NY, USA 3 Department of Medicine, University of Rochester Medical Center , NY, USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Patricia M. White 4 Department of Neuroscience, University of Rochester School of Medicine and Dentistry , Rochester, NY, USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Patricia M. White Ned J. Place 1 Department of Population Medicine and Diagnostic Sciences, Cornell University College of Veterinary Medicine , Ithaca, NY, USA Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: njp27{at}cornell.edu Abstract Full Text Info/History Metrics Preview PDF Abstract The naked mole-rat (NMR) is renowned for being the longest-lived rodent, with a maximum lifespan of over 40 years. This exceptional longevity has been attributed to increased cytoprotective signaling, which has been partially ascribed to a major component of the NMR’s extracellular matrix hyaluronan (HA), which has an unusually large molecular mass in this species. The HA molecular mass in the NMR is five to six times greater than in mice and humans. Mice expressing the transgene for NMR HA synthase 2 ( nmrHas2 ), which is the enzyme that produces very high molecular mass HA (vHMM-HA), had improved health outcomes at an advanced age, such as improved mobility, grip strength, and reduced inflammation. Calorie restriction (CR) similarly improves healthspan in mice, and CR has also been shown to attenuate age-related hearing loss (AHL). Specifically, CR mitigates the effects of a single-nucleotide polymorphism (SNP) in the cadherin 23 ( Cdh23 ) gene, which encodes a protein required for the stability of stereocilia on cochlear hair cells in mice and humans. Therefore, we hypothesized that AHL would be attenuated in nmrHas2+ mice. We performed auditory brainstem response testing on 3-month and 12-month-old mice with (nmrHas2+) and without (nmrHas2-) the NMR transgene. We observed AHL at 12 months of age in both nmrHas2+ and nmrHas2-mice, and AHL was not attenuated by nmrHas2 expression. This suggests that the cytoprotective effects of vHMM-HA work through a different pathway from CR, at least with respect to the inner ear. Introduction The naked mole-rat (NMR) is a rodent renowned for its extreme longevity (40+ years) [ 1 ]. A mechanism that contributes to enhanced longevity in the NMR is increased cytoprotective signaling [ 2 , 3 ]. This is partially attributed to the NMR’s very high molecular mass hyaluronan (also known as hyaluronic acid, vHMM-HA), which is an unbranched disaccharide glucuronic acid/N-acetylglucosamine polymer [ 2 ]. The NMR HMM-HA (6-12 MDa) is five to six times larger than mouse or human HMM-HA (0.5-3 MDa and 0.5-2 MDa, respectively) [ 2 ]. In mice and in humans, HMM-HA undergoes degradation and fragmentation, and when fragments are not properly cleared, this leads to the accumulation of low molecular mass (LMM) HA, which is biologically active and can induce inflammation and fibrosis [ 4 - 6 ]. The very high molecular mass HA (vHMM-HA) in NMRs is resistant to this degradation [ 7 ]. Additionally, binding of vHMM-HA to its receptor, CD44, induces expression of cytoprotective pathways and prevents binding of LMM-HA to CD44 [ 8 ]. A mouse line expressing the transgene for NMR hyaluronan synthase 2 ( nmrHas2 ), which synthesizes vHMM-HA, was shown to have extended longevity, improved health outcomes and decreased inflamm-aging at 24 months of age, which was attributed to the reduced expression of inflammatory cytokines [ 9 ]. These results in the nmrHas2 mouse are similar to the beneficial effects of calorie restriction (CR) [ 10 ]. The nmrHas2 mouse is the subject of an ongoing project that aims to determine whether female reproductive aging is attenuated at 12 months of age after induction of the nmr Has2 transgene at one month of age. As a supplement to the study on female reproductive aging, we added an investigation of age-related hearing loss (AHL), which is also evident by 12 months of age in the background strain (C57Bl/6) for the nmrHas2 mouse. Age-related hearing loss, which can be alleviated in mice by CR, is typically caused by irreversible damage to cochleae that occurs during aging [ 11 , 12 ]. In humans, approximately one in three individuals 65 to 74 years of age self-reports difficulty in hearing, including AHL [ 13 ]. Understanding potential mechanisms that contribute to or alleviate AHL is key to the development of successful therapeutics that attenuate AHL progression. This is increasingly important as global longevity increases, with average life expectancy increasing from 66.8 years in 2000 to 73.6 years in 2019 [ 14 ]. C57Bl/6 mice have pronounced AHL at 12 months of age, which is earlier than most other mouse strains, and is due to a single nucleotide polymorphism (SNP) in the gene cadherin 23 ( Cdh23 ) [ 15 ]. Calorie restriction of C57Bl/6 mice at 12 months of age also prevented AHL [ 16 ]. Owing to the similar outcomes between nmrHas2 expression and CR in healthspan and inflamm-aging, we anticipated nmrHas2 mice would also demonstrate attenuated AHL. Our objective for this study was to perform ABR testing with nmrHas2 + and nmrHas2 -mice at 3 and 12 months of age to test the hypothesis that AHL would be attenuated following induction of nmrHas2 expression at 1 month. Following transgene induction, ubiquitous nmrHas2 expression is maintained throughout life [ 9 ]. Materials and Methods Animal husbandry Mice were group housed and provided with standard chow diet and water ad libitum . All mice were housed under controlled conditions of temperature (range 21–24 °F), 12:12 h light:dark cycles, and relative humidity of 40 - 50%. All experimental procedures were approved by Cornell University’s Institutional Animal Care and Use Committee (protocol number 2020-0057). Transgenic animal design and use Transgenic mice on the C57Bl/6 background were generated as previously described [ 9 ] ( Figure 1A ). We cross bred the nmrHas2 and R26 - creER t2 lines to generate heterozygous nmrHas2 dams and homozygous R26-creER t2 sires. At 21 days of age, we weaned female offspring, placed an ear tag in one ear, and collected ear tissue from the opposite ear for genotype determination. Due to the primary use of these animals for female reproductive aging experiments, we euthanized male offspring at weaning. Download figure Open in new tab Figure 1: Outline of transgenic mouse model and experimental design. A ) Experimental mice were generated by cross breeding sires that are homozygous for the CreER t2 recombinase in exon 1 of Rosa26 (Cre-ER t2 ) with dams that are heterozygous for the nmrHas2 transgene, for which the upstream Neo R -LoxP cassette prevents expression. Litters produced contained nmrHas2+/- x CreER t2 +/- (nmrHas2+) and nmrHas2-/- x CreER t2 +/- (nmrHas2-) offspring. One-month-old female offspring were given daily intraperitoneal injections of 75 mg/kg BW of tamoxifen for 5 days to induce nmrHas2 expression in nmrHas2+ mice and equivalent doses of corn oil (Vehicle) to control for potential effects of tamoxifen. B ) Mice were raised to 3 months or 12 months of age and underwent auditory brainstem response (ABR) threshold testing. The response threshold was determined as the lowest stimulus level (in decibels, dB) that elicited a wave-like pattern of response (in the example, it would be classified as 60 dB). Experimental design is outlined in Figure 1B . We divided female mice into 2 groups based on genotype: nmrHas2 +/-, R26-creER t2 +/- (nmrHas2+, n = 13) and nmrHas2 -/-, R26-creER t2 +/- (nmrHas2-, n = 27). At 30 days of age, we administered 75 mg/kg tamoxifen (Tam; Sigma-Aldrich, St. Louis, MO) in sterile corn oil to mice via intraperitoneal (i.p.) injection daily for 5 days to ubiquitously induce life-time expression of nmrHas2 . We administered equivalent doses of corn oil vehicle (Veh; Sigma-Aldrich, St. Louis, MO) to a subset of nmrHas2-mice to control for the potential effects of Tam treatment. Due to unanticipated expression of nmrHas2 in ovaries of nmrHas2+ mice not administered tamoxifen, only nmrHas2+ mice given tamoxifen were included in these experiments. We raised mice to two target ages: 3 months (young, n = 15) and 12 months of age (old, n = 25). These timepoints correspond with previous literature for normal hearing and AHL in C57Bl/6 mice[ 12 , 17 ]. Animals were separated into 6 groups based on genotype, age, and treatment combination: nmrHas2-× 3 m × Tam (n = 4), nmrHas2-× 3 m × Veh (n = 6), nmrHas2+ × 3 m × Tam (n = 5), nmrHas2-× 12 m × Tam (n = 9), nmrHas2-× 12 m ×Veh (n = 8), and nmrHas2+ × 12 m × Tam (n = 8). Auditory brainstem response (ABR) measurement and analysis Approximately 2 weeks before reaching the target ages for euthanasia and tissue collection, we performed ABR testing on mice. Testing occurred between the hours of 9 AM and 12 PM EST. We deeply anaesthetized mice using an i.p. injection of ketamine (80 mg/kg animal weight) and xylazine (3 mg/kg animal weight). If after 10 minutes the desired plane of anesthesia had not been achieved (i.e. no response to foot pad pinch), an additional half dose of ketamine and xylazine was administered. We placed mice on a non-electric isothermal warming pad (Braintree Scientific, Inc., Braintree, MA) within a sound-proof chamber (Sound Room Solutions, Inc., Glen Cove, NY). We inserted three needle electrodes subcutaneously at the forehead and near each pinna. Electrodes were connected by cables to the ABR testing system (Tucker-Davis Technologies, Inc., Alachua, FL). We first evoked ABR responses using a 50 μsecond click stimuli. Immediately thereafter, we evoked ABR responses using 1 millisecond pure tones at frequencies of 4, 8, 12, 16, 24, and 32 kHz, with evoked responses averaged across 512 sweeps. We recorded responses for each stimulus level in 10 dB steps from 100 dB to 10 dB sound pressure level (SPL) for both clicks and tones. The ABR threshold was defined as the lowest SPL sufficient to elicit at least one peak that was consistent with an ABR waveform ( Figure 1B ). For the purpose of statistical analyses, we recorded animals that did not elicit a peak at any stimuli as having an ABR threshold of 110 dB, which is one 10 dB step above the maximum stimulus tested. A single researcher who was unaware of each animal’s age, Tam vs Veh treatment, and genotype scored ABR thresholds for all click and tone tests. Following the completion of the ABR testing and recovery from anesthesia, we returned mice to their pre-testing housing arrangement. Tissue collection, RNA extraction, and RT-PCR Mice reached target ages approximately two weeks after ABR testing, at which time we individually euthanized mice via CO 2 inhalation. Thereafter, we removed the cochleae by microdissection and processed them for future interrogation if the ABR results indicated AHL had been attenuated or alleviated. We also collected cochleae from a subset of young mice (n = 3 per genotype) for RNA extraction to confirm nmrHas2 expression in the cochlea. For each mouse, we placed both isolated cochleae in a sterile 12-well plate on ice with chilled lysis buffer from the Qiagen RNeasy Plus Kit (QIAGEN; Hilden, Germany). We then broke apart cochleae using sterile forceps and scraped out sensory areas to expose cells to the lysis buffer. We further minced tissue first using sterile scalpel blades followed by homogenization in lysis buffer using Bead-Ruptor Pre-Filled Metal Bead Tubes (Omni International; Kennesaw, GA, USA). We extracted RNA from the homogenized tissue using the Qiagen RNeasy Plus Kit (QIAGEN; Hilden, Germany) and QIAShredder Columns (QIAGEN; Hilden Germany) according to manufacturer’s instructions. We performed qRT-PCR to confirm cochlear expression of nmrHas2 in nmrHas2+ mice. We used approximately 700 μg of extracted RNA to make cDNA using the SuperScript III First-Strand Synthesis kit (Invitrogen; Waltham, MA, USA). Due to the high similarity of Has2 sequences in NMR and mice, we designed primers that were preferential to the NMR Has2 mRNA sequence over the mouse Has2 sequence, but not entirely exclusive. We performed qRT-PCR using primers preferential for nmrHas2 (Forward primer: GAG-AGC-TCA-CAG-GTG-ACA-CAG; Reverse primer: GGA-GTC-ACA-AAC-CTG-CAC-ATA-ATC-CAC-A). We used previously generated cDNA libraries from NMR ovaries as a positive control for nmrHas2 expression and primers specific for mouse Has2 as a positive control for PCR in nmrHas2-mice. We performed gel electrophoresis and gel extraction using the Qiagen QIAQuick Gel extraction kit (Qiagen; Hilden, Germany) to isolate PCR products and confirm their sequences. We performed Sanger sequencing of PCR products at the Cornell Bioinformatics Resource Center using Big Dye Terminator Cycle (Applied Biosystems; Waltham, MA) and confirmed the sequence similarity of PCR products to the NMR Has2 sequence. Statistical design We performed all statical tests in JMP Pro, ver. 17.0.0 (SAS Institute Inc.; Cary, NC, USA). To assess if ABR threshold was different based on age, genotype, or tamoxifen treatment, we first performed a generalized linear model for clicks and all tones. The ABR threshold was the outcome variable and fixed effects were genotype, age, tamoxifen treatment, and genotype × age interaction. We performed the following planned post-hoc contrasts for clicks and all tones: 3 m and 12 m nmrHas2-, 3 m and 12 m nmrHas2+, and 12 m nmrHas2- and 12 m nmrHas2+. We did not observe an effect based on tamoxifen treatment, so this effect was not examined in post-hoc contrasts. Results ABR testing results If AHL was attenuated by nmrHas2 expression, this would manifest as decreased ABR thresholds. For clicks and all tones, ABR thresholds were significantly different based on age ( P ≤ 0.004, Figure 2 , Table S1 ), but not based on genotype ( P ≥ 0.37). Planned post-hoc contrasts demonstrated the mean ABR thresholds were greater in old nmrHas2-mice for clicks and all tones compared to young nmrHas2-mice ( P ≤ 0.006, Table S1). The ABR threshold was greater in old nmrHas2+ mice for clicks and tones at 4, 8, 12, 16, and 24 kHz compared to young nmrHas2+ mice ( P ≤ 0.001), but did not achieve statistical significance at 32 kHz ( P = 0.08, Table S1). The ABR threshold was also not different between old nmrHas2- and nmrHas2+ mice for clicks ( P = 0.26, Figure 2A ) and all tones ( P ≥ 0.26, Figure 2B ). Download figure Open in new tab Figure 2: Results of auditory brainstem response (ABR) testing when 3- and 12-month-old mice that were stimulated with A) clicks and B) pure tones. Expression of naked mole-rat hyaluronan synthase 2 was induced in mice carrying the transgene (nmrHas2+) using intraperitoneal tamoxifen (Tam) injections at 1 month of age. Control mice without the transgene (nmrHas2-) were given either Tam or corn oil vehicle (Veh). The ABR threshold was higher for clicks and tones in old mice compared to young mice, regardless of genotype or tamoxifen treatment, indicating nmrHas2 did not attenuate age-related hearing loss. For differences based on age, ** indicates P < 0.01 and *** indicates P < 0.001. Cochlear expression of nmrHas2 We used extracted RNA to validate expression of nmrHas2 in nmrHas2+ mice. Zhang et al. (2023) established overall Has2 tissue expression was substantially greater in nmrHas2+ mice following Tam induction 22 . Therefore, we used qRT-PCR to evaluate cochlear Has2 expression. Primers preferential for nmrHas2 yielded a single-band product from NMR ovarian cDNA libraries while musHas2 primers yielded no product from the same NMR libararies. Expression of Has2 was substantially greater in the cochleae of nmrHas2+ mice compared to nmrHas2-mice (Fold change = 781.98 ± 234.89 and 1.00 ± 0.38, respectively). These data indicated successful induction of expression of nmrHas2 in the cochleae of nmrHas2+ mice. Discussion The goal of this experiment was to determine whether ubiquitous expression of nmrHas2 transgene, including within the cochleae, attenuated AHL. Ubiquitous expression of nmrHas2 in mice attenuated similar age-associated phenotypes to those previously seen using CR, such as improved overall health and reduced inflammation [ 9 ] Calorie restriction has also been demonstrated to attenuate AHL in mice at 12 months of age [ 16 ]. Therefore, we hypothesized that ubiquitous expression of nmrHas2 , which includes cochleae, would attenuate AHL at 12 months of age in mice. While we demonstrated cochlear expression of the nmrHas2 transgene in nmrHas2+ animals, there was no attenuation of AHL in nmrHas2+ mice at 12 months of age compared to nmrHas2-mice. While the specific cytoprotective mechanisms induced by vHMM-HA in the NMR are not well understood, the cytoprotective pathway regulated by the transcription factor nuclear erythroid 2-related factor 2 (NRF2) is upregulated in the NMR relative to mice [ 3 ]. Typically, Kelch-like ECH-associated protein 1 (KEAP1) sequesters NRF2 in the cytoplasm and leads to NRF2 ubiquitination and degradation [ 18 ]. However, during periods of stress, a conformational change in KEAP1 allows NRF2 translocation to the nucleus to upregulated cytoprotective pathways [ 19 ]. In the NMR, KEAP1 is downregulated, and NRF2 and its downstream targets are continuously upregulated [ 3 ]. In a KEAP1 knock down mouse model, the NRF2-regulated pathways were continuously upregulated, and AHL in C57Bl/6 mice was attenuated at 12 months of age [ 20 ]. Conversely, loss of NRF2 in mice accelerated progression of AHL due to earlier loss of cochlear hair cells [ 21 ]. As a caveat, the upregulation of NRF2 in the cochlea from vHMM-HA expression remains to be determined. Nonetheless, these studies suggested that the nmrHas2 transgene would mitigate AHL in aging mice. As this short report demonstrates that nmrHas2 is not sufficient to overcome AHL in aging C57BL/6 mice, we may speculate on the underlying mechanisms. First, nmrHas2 generates vHMM-HA, which binds to the widely expressed CD44 receptor [ 8 ]. In the cochlear sensory epithelium, only outer pillar cells express CD44 [ 22 ]. Previous reports indicate that CD44 is necessary for the anti-aging effects of vHMM-HA [ 8 ]. Our data indicate that cochlear hair cells were not rescued by the changes in the extracellular environment, possibly because they do not express CD44. Alternatively, NRF2 also plays key roles in cholesterol metabolism [ 23 ]. Cholesterol is a necessary component of the outer hair cell amplification mechanism involving SLC26A5 [ 24 ]. Loss of outer hair cell amplification through changes in cholesterol metabolism could potentially reverse any benefits derived from NRF2 activation or reductions in inflammation. The early onset of AHL in C57Bl/6 mice enabled us to add ABR testing to our larger study on the effects of the nmrHas2 transgene on female reproductive aging at 12 months of age. It appears that, unlike CR, the anti-inflammatory properties of vHMM-HA observed in previous studies using nmrHas2 mice [ 9 ] could not overcome the hair cell intrinsic hearing loss caused by the variant SNP in Cdh23 . One potential reason may be that while nmrHas2 was expressed in the cochlea, it did not generate sufficient vHMM-HA to attenuate AHL. For future studies, a different mouse strain in which AHL occurs through a different mechanism could be used. For example, AHL in CD/1 mice has been attributed to inflammation-induced aging of the cochleae [ 25 ]. Therefore, CD1 mice might be informative in accessing the potential cytoprotective effects of nmrHas2 expression in the cochlea. As inflammation is a common sequelae to noise or drug damage, it will be interesting to see if vHMM-HA can mitigate hearing loss in damage paradigms through its action on endogenous cochlear macrophages [ 26 ]. Lastly, it would be interesting to see if vHMM-HA can alleviate the oxidative stress observed in the mouse cochlea from exogenous factors, such as cigarette smoke exposure [ 27 ]. Overall, we did not observe an attenuation of AHL in mice that ubiquitously express nmrHas2 . However, these data raise questions regarding the mechanism of the cytoprotective effect of vHMM-HA, as only outer pillar cells, and distinctly not outer hair cells, express CD44, a primary receptor for HA. Future studies examining cochlear cell-type specific HA-interactions and exposure to various exogenous factors that cause hearing loss could elucidate the primary cyptoprotective mechanism associated with nmrHas2 expression. Acknowledgements We would like to thank our lab technicians, Rebecca Cubitt and Ruby Feng, for their help in maintaining the nmrHas2 and Cre-ER T2 mouse colonies and i.p. injections to induce expression of the transgene. We would also like to thank our undergraduate researchers, Kristen Dookie, Andy Zhang, Shruti Nagpal, and Posie Price, for their help maintaining the mouse colonies and assisting during tissue collection. References 1. ↵ Ruby JG , Smith M , Buffenstein R. Naked Mole-Rat mortality rates defy gompertzian laws by not increasing with age . Elife . 2018 ; 7 . Epub 2018/01/25. doi: 10.7554/eLife.31157 . PubMed PMID: 29364116 ; PubMed Central PMCID: PMCPMC5783610 . OpenUrl CrossRef PubMed 2. ↵ Tian X , Azpurua J , Hine C , Vaidya A , Myakishev-Rempel M , Ablaeva J , et al. High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat . Nature . 2013 ; 499 ( 7458 ): 346 – 9 . doi: 10.1038/nature12234 . OpenUrl CrossRef PubMed Web of Science 3. ↵ Lewis KN , Wason E , Edrey YH , Kristan DM , Nevo E , Buffenstein R. Regulation of Nrf2 signaling and longevity in naturally long-lived rodents . Proceedings of the National Academy of Sciences . 2015 ; 112 ( 12 ): 3722 – 7 . doi: 10.1073/pnas.1417566112 . OpenUrl Abstract / FREE Full Text 4. ↵ Monslow J , Govindaraju P , Puré E. Hyaluronan – A Functional and Structural Sweet Spot in the Tissue Microenvironment . Frontiers in Immunology . 2015 ; 6 . doi: 10.3389/fimmu.2015.00231 . OpenUrl CrossRef PubMed 5. Papakonstantinou E , Roth M , Karakiulakis G. Hyaluronic acid: A key molecule in skin aging . Dermatoendocrinol . 2012 ; 4 ( 3 ): 253 – 8 . Epub 2013/03/08. doi: 10.4161/derm.21923 . PubMed PMID: 23467280 ; PubMed Central PMCID: PMCPMC3583886 . OpenUrl CrossRef PubMed 6. ↵ Robert L , Robert AM , Renard G. Biological effects of hyaluronan in connective tissues, eye, skin, venous wall . Role in aging. Pathologie Biologie . 2010 ; 58 ( 3 ): 187 – 98 . doi: 10.1016/j.patbio.2009.09.010 . OpenUrl CrossRef PubMed 7. ↵ Sato S , Mizutani Y , Abe M , Fukuda S , Higashiyama S , Inoue S. Naked mole-rat TMEM2 lacks physiological hyaluronan-degrading activity . Arch Biochem Biophys . 2024 ; 759 : 110098 . Epub 2024/07/16. doi: 10.1016/j.abb.2024.110098 . PubMed PMID: 39009271 . OpenUrl CrossRef PubMed 8. ↵ Takasugi M , Firsanov D , Tombline G , Ning H , Ablaeva J , Seluanov A , et al. Naked mole-rat very-high-molecular-mass hyaluronan exhibits superior cytoprotective properties . Nature Communications . 2020 ; 11 ( 1 ): 2376 . doi: 10.1038/s41467-020-16050-w . OpenUrl CrossRef PubMed 9. ↵ Zhang Z , Tian X , Lu JY , Boit K , Ablaeva J , Zakusilo FT , et al. Increased hyaluronan by naked mole-rat Has2 improves healthspan in mice . Nature . 2023 ; 621 ( 7977 ): 196 – 205 . doi: 10.1038/s41586-023-06463-0 . OpenUrl CrossRef PubMed 10. ↵ Kökten T , Hansmannel F , Ndiaye NC , Heba AC , Quilliot D , Dreumont N , et al. Calorie Restriction as a New Treatment of Inflammatory Diseases . Adv Nutr . 2021 ; 12 ( 4 ): 1558 – 70 . Epub 2021/02/09. doi: 10.1093/advances/nmaa179 . PubMed PMID: 33554240 ; PubMed Central PMCID: PMCPMC8321869 . OpenUrl CrossRef PubMed 11. ↵ Lin FR , Niparko JK , Ferrucci L. Hearing loss prevalence in the United States . Arch Intern Med . 2011 ; 171 ( 20 ): 1851 – 2 . Epub 2011/11/16. doi: 10.1001/archinternmed.2011.506 . PubMed PMID: 22083573 ; PubMed Central PMCID: PMCPMC3564588 . OpenUrl CrossRef PubMed Web of Science 12. ↵ Yang CH , Schrepfer T , Schacht J. Age-related hearing impairment and the triad of acquired hearing loss . Front Cell Neurosci . 2015 ; 9 : 276 . Epub 2015/08/19. doi: 10.3389/fncel.2015.00276 . PubMed PMID: 26283913 ; PubMed Central PMCID: PMCPMC4515558 . OpenUrl CrossRef PubMed 13. ↵ Cassarly C , Matthews LJ , Simpson AN , Dubno JR . The Revised Hearing Handicap Inventory and Screening Tool Based on Psychometric Reevaluation of the Hearing Handicap Inventories for the Elderly and Adults . Ear Hear . 2020 ; 41 ( 1 ): 95 – 105 . Epub 2019/05/28. doi: 10.1097/aud.0000000000000746 . PubMed PMID: 31124792 ; PubMed Central PMCID: PMCPMC6864238 . OpenUrl CrossRef PubMed 14. ↵ Wang H , Abbas KM , Abbasifard M , Abbasi-Kangevari M , Abbastabar H , Abd-Allah F , et al. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019 . The Lancet . 2020 ; 396 ( 10258 ): 1160 – 203 . doi: 10.1016/S0140-6736(20)30977-6 . OpenUrl CrossRef PubMed 15. ↵ Noben-Trauth K , Zheng QY , Johnson KR . Association of cadherin 23 with polygenic inheritance and genetic modification of sensorineural hearing loss . Nature Genetics . 2003 ; 35 ( 1 ): 21 – 3 . doi: 10.1038/ng1226 . OpenUrl CrossRef PubMed Web of Science 16. ↵ Someya S , Yamasoba T , Weindruch R , Prolla TA , Tanokura M. Caloric restriction suppresses apoptotic cell death in the mammalian cochlea and leads to prevention of presbycusis . Neurobiology of Aging . 2007 ; 28 ( 10 ): 1613 – 22 . doi: 10.1016/j.neurobiolaging.2006.06.024 . OpenUrl CrossRef PubMed Web of Science 17. ↵ Nemoto M , Morita Y , Mishima Y , Takahashi S , Nomura T , Ushiki T , et al. Ahl3, a third locus on mouse chromosome 17 affecting age-related hearing loss . Biochemical and Biophysical Research Communications . 2004 ; 324 ( 4 ): 1283 – 8 . doi: 10.1016/j.bbrc.2004.09.186 . OpenUrl CrossRef PubMed Web of Science 18. ↵ Lewis KN , Mele J , Hayes JD , Buffenstein R. Nrf2, a Guardian of Healthspan and Gatekeeper of Species Longevity . Integrative and Comparative Biology . 2010 ; 50 ( 5 ): 829 – 43 . doi: 10.1093/icb/icq034 . OpenUrl CrossRef PubMed Web of Science 19. ↵ Suzuki T , Yamamoto M. Stress-sensing mechanisms and the physiological roles of the Keap1–Nrf2 system during cellular stress . Journal of Biological Chemistry . 2017 ; 292 ( 41 ): 16817 – 24 . doi: 10.1074/jbc.R117.800169 . OpenUrl Abstract / FREE Full Text 20. ↵ Oishi T , Matsumaru D , Ota N , Kitamura H , Zhang T , Honkura Y , et al. Activation of the NRF2 pathway in Keap1-knockdown mice attenuates progression of age-related hearing loss . npj Aging and Mechanisms of Disease . 2020 ; 6 ( 1 ): 14 . doi: 10.1038/s41514-020-00053-4 . OpenUrl CrossRef 21. ↵ Hoshino T , Tabuchi K , Nishimura B , Tanaka S , Nakayama M , Ishii T , et al. Protective role of Nrf2 in age-related hearing loss and gentamicin ototoxicity . Biochemical and Biophysical Research Communications . 2011 ; 415 ( 1 ): 94 – 8 . doi: 10.1016/j.bbrc.2011.10.019 . OpenUrl CrossRef PubMed 22. ↵ Hertzano R , Puligilla C , Chan S-L , Timothy C , Depireux DA , Ahmed Z , et al. CD44 is a Marker for the Outer Pillar Cells in the Early Postnatal Mouse Inner Ear . Journal of the Association for Research in Otolaryngology . 2010 ; 11 ( 3 ): 407 – 18 . doi: 10.1007/s10162-010-0211-x . OpenUrl CrossRef PubMed 23. ↵ Wai KW , Low LE , Goh BH , Yap WH . Nrf2 Connects Cellular Autophagy and Vascular Senescence in Atherosclerosis: A Mini-Review . J Lipid Atheroscler . 2024 ; 13 ( 3 ): 292 – 305 . OpenUrl PubMed 24. ↵ Takahashi S , Homma K , Zhou Y , Nishimura S , Duan C , Chen J , et al. Susceptibility of outer hair cells to cholesterol chelator 2-hydroxypropyl-β-cyclodextrine is prestin-dependent . Scientific Reports . 2016 ; 6 ( 1 ): 21973 . doi: 10.1038/srep21973 . OpenUrl CrossRef PubMed 25. ↵ Riva C , Donadieu E , Magnan J , Lavieille J-P. Age-related hearing loss in CD/1 mice is associated to ROS formation and HIF target proteins up-regulation in the cochlea . Experimental Gerontology . 2007 ; 42 ( 4 ): 327 – 36 . doi: 10.1016/j.exger.2006.10.014 . OpenUrl CrossRef PubMed 26. ↵ Sato E , Shick HE , Ransohoff RM , Hirose K. Expression of Fractalkine Receptor CX3CR1 on Cochlear Macrophages Influences Survival of Hair Cells Following Ototoxic Injury . Journal of the Association for Research in Otolaryngology . 2010 ; 11 ( 2 ): 223 – 34 . doi: 10.1007/s10162-009-0198-3 . OpenUrl CrossRef PubMed 27. ↵ Paquette ST , Dawes RP , Sundar IK , Rahman I , Brown EB , White PM . Chronic cigarette smoke exposure drives spiral ganglion neuron loss in mice . Scientific Reports . 2018 ; 8 ( 1 ): 5746 . doi: 10.1038/s41598-018-24166-9 . OpenUrl CrossRef PubMed View the discussion thread. Back to top Previous Next Posted July 31, 2025. Download PDF Email Thank you for your interest in spreading the word about bioRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Expression of the naked mole-rat transgene for Has2 improved health span in C57Bl/6 mice, but it did not attenuate age-related hearing loss Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Expression of the naked mole-rat transgene for Has2 improved health span in C57Bl/6 mice, but it did not attenuate age-related hearing loss Connor E. Owens , Aiden J. Borruso , Kevin A. Place , Andrei Seluanov , Vera Gorbunova , Patricia M. White , Ned J. Place bioRxiv 2025.07.27.667071; doi: https://doi.org/10.1101/2025.07.27.667071 Share This Article: Copy Citation Tools Expression of the naked mole-rat transgene for Has2 improved health span in C57Bl/6 mice, but it did not attenuate age-related hearing loss Connor E. Owens , Aiden J. Borruso , Kevin A. Place , Andrei Seluanov , Vera Gorbunova , Patricia M. White , Ned J. Place bioRxiv 2025.07.27.667071; doi: https://doi.org/10.1101/2025.07.27.667071 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Neuroscience Subject Areas All Articles Animal Behavior and Cognition (7635) Biochemistry (17697) Bioengineering (13894) Bioinformatics (41951) Biophysics (21455) Cancer Biology (18592) Cell Biology (25507) Clinical Trials (138) Developmental Biology (13380) Ecology (19903) Epidemiology (2067) Evolutionary Biology (24321) Genetics (15610) Genomics (22509) Immunology (17737) Microbiology (40398) Molecular Biology (17182) Neuroscience (88618) Paleontology (667) Pathology (2833) Pharmacology and Toxicology (4825) Physiology (7641) Plant Biology (15158) Scientific Communication and Education (2046) Synthetic Biology (4296) Systems Biology (9825) Zoology (2271)
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.